Skip to main content
. 2015 Apr 29;10(4):e0125287. doi: 10.1371/journal.pone.0125287

Fig 1. Frequency of pp65-specific T cells in patients taking acyclovir and in control subjects.

Fig 1

IFN-γ production was determined in the total T cell population following stimulation with pp65 peptide pool using PBMC taken from ACV-treated subjects and control subjects (A). The individual responses of CD4+ T cells (B) and CD8+ T cells (C) are also shown. In (D-F) the proportion of pp65-specific T cells is represented accordingly in samples from donors who had been taking acyclovir for periods of 1–11 months, 12–48 months or over 4 years (n = 9, 8, 7 respectively). Means (A-C) or means with SEM (D-F) are shown.